T. Rowe Price Investment Management, Inc. Portfolio Holdings

T. Rowe Price Investment Management, Inc.

  • $166 Billion
  • Q3 2024

T. Rowe Price Investment Management, Inc. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $166 Billion distributed in 622 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $5.02B, Nvidia Corp with a value of $3.11B, Fortive Corp with a value of $3.09B, Amazon Com Inc with a value of $2.89B, and Ptc Inc. with a value of $2.8B.

Examining the 13F form we can see an increase of $7.38B in the current position value, from $158B to 166B.

T. Rowe Price Investment Management, Inc. is based out at Baltimore, MD

Below you can find more details about T. Rowe Price Investment Management, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $166 Billion
Technology: $39.8 Billion
Healthcare: $32.3 Billion
Industrials: $19.4 Billion
Consumer Cyclical: $18.6 Billion
Financial Services: $16.8 Billion
Energy: $6.98 Billion
Utilities: $6.1 Billion
Basic Materials: $5.54 Billion
Other: $11.5 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$269M
$32.9 Million 0.02% of portfolio
884,334
Q3 2024 Added 11.83%
$3.55B
$32.9 Million 0.02% of portfolio
650,906
Q3 2024 Reduced 4.18%
$2.86B
$34.2 Million 0.02% of portfolio
428,331
Q3 2024 Added 9.01%
$12.5B
$25.2 Million 0.02% of portfolio
120,860
Q3 2024 Added 0.23%
$1.5B
$27 Million 0.02% of portfolio
566,914
Q3 2024 Added 20.16%
Structure Therapeutics Inc
-
$31.4 Million 0.02% of portfolio
-
Q3 2024 Added 2.8%
$7.52B
$31.9 Million 0.02% of portfolio
227,708
Q3 2024 Reduced 1.55%
$410M
$25.4 Million 0.02% of portfolio
2,023,316
Q3 2024 Added 95.26%
$416M
$38.4 Million 0.02% of portfolio
2,830,248
Q3 2024 Added 109.77%
$5.23B
$40.1 Million 0.02% of portfolio
476,055
Q3 2024 Added 16.28%
$2.47B
$35.2 Million 0.02% of portfolio
369,542
Q3 2024 Added 18.93%
Rapport Therapeutics Inc
-
$35.4 Million 0.02% of portfolio
-
Q3 2024 Added 12.5%
$550M
$28.5 Million 0.02% of portfolio
4,756,137
Q3 2024 Reduced 0.44%
$2.53B
$38.6 Million 0.02% of portfolio
378,045
Q3 2024 Added 291.45%
$4.26B
$36.7 Million 0.02% of portfolio
1,574,706
Q3 2024 Reduced 44.83%
$9.55B
$32 Million 0.02% of portfolio
828,566
Q3 2024 Reduced 94.22%
$5.03B
$37 Million 0.02% of portfolio
965,958
Q3 2024 Reduced 4.09%
$2.16B
$38.6 Million 0.02% of portfolio
4,202,810
Q3 2024 Added 0.52%
$6.92B
$26.6 Million 0.02% of portfolio
183,359
Q3 2024 New
$1.33B
$37.3 Million 0.02% of portfolio
1,300,096
Q3 2024 Reduced 26.43%
$379M
$26.5 Million 0.02% of portfolio
3,814,170
Q3 2024 New
$1.32B
$37.1 Million 0.02% of portfolio
1,627,965
Q3 2024 Reduced 8.93%
$292M
$35.4 Million 0.02% of portfolio
1,788,668
Q3 2024 Added 8.96%
$268M
$38.7 Million 0.02% of portfolio
5,023,146
Q3 2024 Added 5.62%
$2.59B
$41.1 Million 0.02% of portfolio
1,067,378
Q3 2024 Added 10.71%
$554M
$34.6 Million 0.02% of portfolio
2,725,877
Q3 2024 Added 3.23%
$495M
$26.6 Million 0.02% of portfolio
3,867,142
Q3 2024 Reduced 16.42%
$1.26B
$27.2 Million 0.02% of portfolio
3,005,867
Q3 2024 Reduced 4.3%
$3.34B
$31.9 Million 0.02% of portfolio
2,076,249
Q3 2024 Added 24.25%
$828M
$39.2 Million 0.02% of portfolio
6,712,036
Q3 2024 Added 0.02%
$324M
$27.1 Million 0.02% of portfolio
795,017
Q3 2024 Added 4.0%
$3.38B
$40.6 Million 0.02% of portfolio
1,578,048
Q3 2024 Added 7.02%
$3.36B
$40.2 Million 0.02% of portfolio
265,413
Q3 2024 Added 142.07%
$5.84B
$35.1 Million 0.02% of portfolio
668,887
Q3 2024 New
$7.47B
$38.8 Million 0.02% of portfolio
872,533
Q3 2024 Added 33.11%
$4.07B
$31.5 Million 0.02% of portfolio
1,164,837
Q3 2024 Reduced 87.61%
$2.81B
$34.3 Million 0.02% of portfolio
536,022
Q3 2024 New
$9.16B
$36.6 Million 0.02% of portfolio
217,723
Q3 2024 Added 35.64%
$3.14B
$26.1 Million 0.02% of portfolio
844,142
Q3 2024 New
$16.3B
$27.6 Million 0.02% of portfolio
56,165
Q3 2024 Reduced 1.6%
$1.91B
$30.1 Million 0.02% of portfolio
429,736
Q3 2024 Added 10.72%
$5.66B
$35.7 Million 0.02% of portfolio
473,752
Q3 2024 Reduced 8.2%
$280M
$27.7 Million 0.02% of portfolio
2,703,521
Q3 2024 Reduced 0.06%
$1.21B
$33.7 Million 0.02% of portfolio
888,033
Q3 2024 Reduced 0.06%
$4.01B
$31.4 Million 0.02% of portfolio
525,973
Q3 2024 Reduced 2.01%
$96.7B
$8.55 Million 0.01% of portfolio
96,748
Q3 2024 Added 5.07%
$10.1B
$24.6 Million 0.01% of portfolio
18,692
Q3 2024 Reduced 26.18%
$8.5B
$18.3 Million 0.01% of portfolio
919,005
Q3 2024 New
$2B
$19.6 Million 0.01% of portfolio
754,005
Q3 2024 Reduced 38.4%

Summary

  • Portfolio
  • No. of Stocks 622
  • Current Value $166 Billion
  • Prior Value $158 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 47 stocks
  • Additional Purchases 262 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 312 stocks
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email